NEVIRAPINE Pharmacologic Class Indexing
- Class set ID
- 743552e6-ac73-4699-bb8d-b2add5404cf9
- Version
- 3
- Effective date
- 20181113
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, for oral use Initial U.S. Approval: 1996 | Micro Labs Limited | 20251016 | 13 |
| These highlights do not include all the information needed to use NEVIRAPINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE EXTENDED-RELEASE TABLETS. NEVIRAPINE extended-release tablets, for oral use Initial U.S. Approval: 1996 | Mylan Pharmaceuticals Inc. | 20241015 | 10 |
| These highlights do not include all the information needed to use NEVIRAPINE ORAL SUSPENSION safely and effectively. See full prescribing information for NEVIRAPINE ORAL SUSPENSION. NEVIRAPINE oral suspension Initial U.S. Approval: 1996 | Aurobindo Pharma Limited | 20240904 | 12 |
| These highlights do not include all the information needed to use NEVIRAPINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE EXTENDED-RELEASE TABLETS. NEVIRAPINE extended-release tablets, for oral use Initial U.S. Approval: 1996 | Macleods Pharmaceuticals Limited | 20240814 | 6 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, for oral use Initial U.S. Approval: 1996 | Aurobindo Pharma Limited | 20240520 | 9 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, for oral use Initial U.S. Approval: 1996 | Mylan Pharmaceuticals Inc. | 20240115 | 10 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, for oral use Initial U.S. Approval: 1996 | Macleods Pharmaceuticals Limited | 20230816 | 3 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, USP for oral use. Initial U.S. Approval: 1996 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III | 20220803 | 15 |
| These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE Tablets USP, 200 mg, for oral use Initial U.S. Approval: 1996 | Cipla Ltd. | Cipla Ltd.- Goa | 20181127 | 6 |
| These highlights do not include all the information needed to use nevirapine tablets, USP safely and effectively. See full prescribing information for nevirapine tablets, USP. Nevirapine tablets, USP 200 mg, for oral use Initial U.S. Approval: 1996 | State of Florida DOH Central Pharmacy | 20150110 | 1 |
| These highlights do not include all the information needed to use nevirapine tablets safely and effectively. See full prescribing information for nevirapine tablets. Nevirapine Tablets USP, 200 mg Initial U.S. Approval: 1996 | State of Florida DOH Central Pharmacy | 20130926 | 1 |
| These highlights do not include all the information needed to use Nevirapine safely and effectively. See full prescribing information for Nevirapine. Nevirapine Tablets, USP 200 mg for oral use Initial U.S. Approval: 1996 | Amneal Pharmaceuticals LLC | Strides Arcolab Limited | 20120830 | 10 |
| These highlights do not include all the information needed to use VIRAMUNE safely and effectively. See full prescribing information for VIRAMUNE. Viramune® (nevirapine) tablets 200 mg Viramune® (nevirapine) oral suspension 50 mg/5 mL Initial U.S. Approval: 1996 | State of Florida DOH Central Pharmacy | 20100521 | 1 |